Written answers
Thursday, 11 February 2021
Department of Health
Drugs Payment Scheme
Colm Burke (Cork North Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source
266. To ask the Minister for Health if the drug patisiran, or Onpattro, which was recently reviewed by the National Centre for Pharmacoeconomics, will be available under the drugs payment scheme to those who have been identified as requiring the medication for their care; and if he will make a statement on the matter [7588/21]
Colm Burke (Cork North Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source
267. To ask the Minister for Health the reimbursement status of patisiran; when the treatment will be made available for eligible patients in Ireland; and if he will make a statement on the matter. [7589/21]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 266 and 267 together.
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments